CompletedNot Applicable

Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma

United States77 participantsStarted 2011-12

Plain-language summary

This research trial studies biomarkers in tumor tissue samples from younger patients with rhabdomyosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma specimens from the Children Oncology Group (COG) tumor microarrays (TMAs)

What they're measuring

CRKL expression at the protein level

Timeframe: 1 month

Trial details

NCT IDNCT01496573

SponsorChildren's Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2016-05

View on ClinicalTrials.gov More Alveolar Childhood Rhabdomyosarcoma trials